Successful surgical management of primary abdominal wall mucormycosis in an immunocompetent patient

Krishna Ramavath; Kailash Kurdiya; Satish Subbiah Nagaraj; Lileswar Kaman; Arunanshu Behera; Cherring Tandup

doi:10.18203/2349-2902.isj20212736

Authors

Krishna Ramavath Department of General Surgery, AIIMS, Bibinagar, Telangana, India
Kailash Kurdiya Department of General Surgery, Post Graduate Institute of Medical Education and Research, Sector 12, Chandigarh, India
Satish Subbiah Nagaraj Department of General Surgery, Post Graduate Institute of Medical Education and Research, Sector 12, Chandigarh, India
Lileswar Kaman Department of General Surgery, Post Graduate Institute of Medical Education and Research, Sector 12, Chandigarh, India
Arunanshu Behera Department of General Surgery, Post Graduate Institute of Medical Education and Research, Sector 12, Chandigarh, India
Cherring Tandup Department of General Surgery, Post Graduate Institute of Medical Education and Research, Sector 12, Chandigarh, India

DOI:

https://doi.org/10.18203/2349-2902.isj20212736

Keywords:

Primary cutaneous mucormycosis, Immunocompetent, Abdominal wall, Skin grafting

Abstract

Primary abdominal wall mucormycosis rarely occur in immunocompetent, non-diabetic patients but may affectin patients with traumatic injury with contaminated wounds and patients underlying malignancies usually infiltrating into skin. Herein we are reporting a case of primary cutaneous mucormycosis in a 17-year-old male without immunodeficiency or any comorbidity. He was managed with multiple debridement of the wound and intravenous amphotericin B therapy with cumulative dose of 2000 mg of liposomal amphotericin B followed by split skin grafting. We would like to emphasize the importance of high index of suspicionof fungal sepsis and early start of antifungal therapy in this condition can reduce high rate of mortality and management of large wound with split skin grafting in same setting to avoid morbidity.

Metrics

Metrics Loading ...

Author Biography

Krishna Ramavath, Department of General Surgery, AIIMS, Bibinagar, Telangana, India

dept of general surgery

References

Paltauf A. Mucormycosismucorina. Virchows Arch Pathol Anat.1885;102:543-64.

Tapish S, Taha M, Naresh G. Primary mucormycosis of abdominal wall: A rare fungal infection in a immunocompetent patient. Indian J Surg. 2010;72:306-8.

Alan MS. Agents of mucormycosis & related species. In Mandell, Douglas, and Bennett’s principles and practice of infectious diseases. Gerald LM, John EB, Raphael D, (Eds.). 6th edition. Churchill Livingstone, Philadelphia. 2005;2973-84.

Tehmeena W, Hussain W, Zargar HR, Sheikh AR, Iqbal S. Primary cutaneous mucormycosis in an immunocompetent host. Mycopathologia. 2007;164:197-9.

Kwon-Chung KJ, Bennett JW. Medical Mycology. Philadelphia Lea and Febiger. 1992.

Baraia J, Munoz P. Cutaneous mucormycosis in a heart transplant patient associated with a peripheral catheter. Eur J Clin Microbiol Infect Dis. 1995;14:813-5.

Ng TC, Denning DW. Liposomal Amphotericin B (AmBisome) therapy in invasive fungal infections. Arch Intern Med. 1995;155:1093-8.

Mileshkin L, Slavin M, Seymour JF, Mckenzie A. Successful treatment of rhinocerebralzygomycosis using liposomal nystatin. Leuk Lymph. 2001;42:1119-23.